Smoking and schizophrenia
β Scribed by Joseph P. McEvoy; John Lindgren
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 337 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
β¦ Synopsis
Patients with schizophrenia smoke at a higher prevalence rate (80%) than the general population (30%). Those patients with schizophrenia who smoke have an earlier age of onset and may have more refractory psychopathology. Smoking improves sensory gating, sustained attention, and cognitive performance in patients with schizophrenia.
Conventional antipsychotic drugs initially increase smoking, Switching to the atypical antipsychotic, clozapine, decreases smoking. Smoking decreases the bioavailability of many antipsychotic drugs.
π SIMILAR VOLUMES
Several previous investigations have suggested that the gene for the β£7-nicotinic receptor may play a role in the pathogenesis of schizophrenia and may be responsible for the heavy smoking among schizophrenic patients. In a study of 129 healthy controls and 127 schizophrenic, schizoaffective, and bi
Objective: Smoking is generally on the decline, but more people with disorders such as schizophrenia smoke than is the rule for the general population. Collectively, health professionals in primary or specialist care settings probably do not do as much as they could to help these people cut down or